Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.


Issue 13, 2017
Previous Article Next Article

Antineoplastic drugs and their analysis: a state of the art review

Author affiliations

Abstract

The number of patients suffering from cancer is constantly increasing and, consequently, the number of different chemotherapy treatments administered is increasing. Given the high reactivity and toxicity of antineoplastic drugs, analytical methods are required in all pharmaceutical fields, from drug development to their elimination in wastewater; including formulation quality control, environment and human exposure and therapeutic drug monitoring. The aim of this paper is to provide an overview of the analytical methods available for the determination of antineoplastic drugs in different matrices such as pharmaceutical formulations, biological and environmental samples. The applicability and performance of the reported methods will be critically discussed, with focus on the most commonly used antineoplastic drugs. Only conventional compounds and small molecules for targeted therapy will be considered in the present review.

Graphical abstract: Antineoplastic drugs and their analysis: a state of the art review

Back to tab navigation

Article information


Submitted
02 Mar 2017
Accepted
10 May 2017
First published
15 May 2017

Analyst, 2017,142, 2273-2321
Article type
Critical Review

Antineoplastic drugs and their analysis: a state of the art review

N. Guichard, D. Guillarme, P. Bonnabry and S. Fleury-Souverain, Analyst, 2017, 142, 2273
DOI: 10.1039/C7AN00367F

Social activity

Search articles by author

Spotlight

Advertisements